Elanco Animal Health (ELAN) Tops Q4 EPS by 2c ; Offers Guidance

Elanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.13, $0.02 better than the analyst estimate of $0.11. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.09 billion.

GUIDANCE:

Elanco Animal Health sees FY2026 EPS of $1.00-$1.06, versus the consensus of $1.03. Elanco Animal Health sees FY2026 revenue of $4.95-5.02 billion, versus the consensus of $4.94 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Rubio to visit Gulf states amid Iran deal concerns
• FDA launches Operation TrialBlazer to accelerate drug research